This week's Diabetes Bulletin...

...

Friday 25 April 2008

Accepted for restricted use within NHS Scotland

Scottish Medicines Consortium (SMC): http://www.scottishmedicines.org/

* vildagliptin (Galvus) for type 2 diabetes as dual oral therapy in combination with metformin, when the addition of sulphonylureas is not appropriate

* insulin glulisine (Apidra Solostar) for the treatment of adults, adolescents and children of 6 years and above with diabetes mellitus, where treatment with insulin is required. Use is restricted to adult patients for whom treatment with this insulin analogue is appropriate, and in whom the use of a pre-filled pen offers advantages over a pen and cartridge device.

* insulin glargine (Lantus Solostar) for the treatment of adults, adolescents and children of 6 years and above with diabetes mellitus, where treatment with insulin is required. It may be used in patients in whom treatment with this insulin analogue is appropriate and in whom the use of a pre-filled pen offers advantages over a pen and cartridge device.

No comments: